| Modality | Program | Discovery | Preclinical | IND-enabling | Phase 1 |
|---|---|---|---|---|---|
Small |
CR-C003inflammatory Bowel Disease (IBD)Rheumatoid arthritis (RA)Multiple Sclerosis (MS) |
 |
|||
Therapeutic |
CR-T1-T4Hidradenitis Suppurativa (HS) |
 |
|||
CR-T2-T4Inflammatory Bowel Disease (IBD)Multiple Sclerosis (MS) |
 |
||||
CR-T2-T6Inflammatory Bowel Disease (IBD) |
|